ALGN

ALGN

USD

Align Technology Inc. Common Stock

$183.350+1.840 (1.014%)

Real-time Price

Healthcare
Medical Instruments & Supplies
United States

Price Chart

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$181.510

High

$184.500

Low

$180.000

Volume

0.17M

Company Fundamentals

Market Cap

13.5B

Industry

Medical Instruments & Supplies

Country

United States

Trading Stats

Avg Volume

1.23M

Exchange

NMS

Currency

USD

52-Week Range

Low $141.74Current $183.350High $313.29

AI Analysis Report

Last updated: Apr 27, 2025
AI-GeneratedData Source: Yahoo Finance, Bloomberg, SEC

ALGN (Align Technology Inc. Common Stock): What's Happening and What to Watch

Stock Symbol: ALGN Generate Date: 2025-04-27 23:20:53

Let's break down what's been going on with Align Technology, the company behind those popular Invisalign clear braces and dental scanners. We'll look at the latest news, how the stock price has been moving, and what some signals might suggest for the near future.

Recent News Buzz: A Mixed Bag

The news flow for ALGN lately feels a bit like a tug-of-war.

On one hand, you had some analysts hitting the brakes. HSBC, for instance, downgraded the stock from a "Buy" rating all the way down to "Hold" and slashed their price target significantly, from $290 to $170. That's a pretty big cut and signals a much more cautious view from their side. UBS also lowered their price target, though they kept their "Neutral" rating. Analyst downgrades like these often weigh on a stock because they reflect professional opinions on future prospects or current valuation.

But then, Align announced something positive: the commercial launch of a new Invisalign system designed specifically for kids and teens needing help with jaw alignment issues while also straightening their teeth. This new product, featuring "occlusal blocks," seems like a genuine innovation aimed at a key market segment. Good news about new products can definitely give a company a boost, showing they're still innovating.

So, the news picture is mixed. You have analysts getting more cautious and lowering expectations, clashing with the company pushing out new, potentially impactful products.

Price Check: A Rocky Ride

Looking at the stock's journey over the last few months, it's been a tough stretch. Back in late January, the stock was trading up around the $230-$235 mark. Since then, it's seen a pretty significant decline.

The price data shows a clear downtrend taking hold through February and March, hitting a low around $141 in early April. More recently, in the days leading up to April 25th (the last data point), the stock has shown signs of bouncing back a bit, climbing from that low point up to $183.35.

Comparing the last price ($183.35) to the overall trend, it's still well below where it was a few months ago, but it has managed a noticeable recovery from its recent bottom.

Now, the AI prediction for the next few days is interesting. It forecasts positive percentage changes: +2.28% for today, +1.85% for the next day, and +2.69% the day after. This suggests the AI sees this recent bounce continuing in the very short term.

Putting It Together: Outlook & Ideas

So, what does this all suggest?

The analyst downgrades point to potential headwinds or concerns about the company's valuation or growth trajectory from a professional standpoint. That's a bearish signal. However, the stock has already taken a big hit, and the recent price action shows a bounce off the lows. Plus, the AI model is predicting further upward movement in the immediate future.

Based specifically on the recent price bounce and the AI's short-term positive prediction, the apparent near-term leaning seems to favor potential buyers, suggesting there might be a window for continued upward momentum in the very short term, despite the analyst caution.

Potential Entry Consideration: If you were considering this stock based on the recent bounce and AI prediction, a potential area to watch for entry could be around the current price level ($183.35) or perhaps on a slight dip back towards the $180-$183 range. The AI recommendation data also flags entry points around $183.35 and $184.10, aligning with the recent price. This area looks interesting because it's where the stock recently found some buying support after its big drop.

Potential Exit/Stop-Loss Consideration: Managing risk is key. If the stock were to reverse course and fall below recent support levels, that could signal the bounce is over. The AI recommendation suggests a stop-loss at $165.08. This level is well below the recent trading range and would represent a significant break down if reached. For taking profits, the AI projects a potential target price of $217.76 and a take-profit level at $195.67. The $195.67 level is closer to the recent trading range and could be a near-term target if the upward momentum continues.

Company Context

Remember, Align Technology makes products for straightening teeth and dental scanning. The new product announcement fits right into their core business, potentially opening up new revenue streams. However, the analyst concerns might be related to broader market conditions, competition, or the pace of adoption for their products. The stock's price has fallen significantly from its 52-week high of $313.29, but is also well above its 52-week low of $141.74, showing just how volatile it can be.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can move in unexpected ways. Always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Related News

Analyst Upgrades

HSBC Downgrades Align Technology to Hold, Lowers Price Target to $170

HSBC analyst Sidharth Sahoo downgrades Align Technology from Buy to Hold and lowers the price target from $290 to $170.

View more
HSBC Downgrades Align Technology to Hold, Lowers Price Target to $170
BusinessWire

Align Technology Announces Commercial Availability of Invisalign® System With Mandibular Advancement Featuring Occlusal Blocks for Class II Skeletal and Dental Correction for the United States and Canada at AAO

Offers an Innovative Treatment Option for Class II Skeletal Malocclusion in Kids and Teenage Patients While Simultaneously Straightening their Teeth Align's new Invisalign® System with mandibular advancement

View more
Align Technology Announces Commercial Availability of Invisalign® System With Mandibular Advancement Featuring Occlusal Blocks for Class II Skeletal and Dental Correction for the United States and Canada at AAO
Analyst Upgrades

UBS Maintains Neutral on Align Technology, Lowers Price Target to $215

UBS analyst Kevin Caliendo maintains Align Technology with a Neutral and lowers the price target from $240 to $215.

View more
UBS Maintains Neutral on Align Technology, Lowers Price Target to $215

AI PredictionBeta

AI Recommendation

Bullish

Updated at: Apr 27, 2025, 03:12 PM

BearishNeutralBullish

74.1% Confidence

Risk & Trading

Risk Level3/5
Medium Risk
Suitable For
ConservativeAggressive
Trading Guide

Entry Point

$183.35

Take Profit

$195.67

Stop Loss

$165.08

Key Factors

PDI 5.9 is above MDI 4.0 with ADX 11.2, suggesting bullish trend
Current Price is extremely close to support level ($183.04), suggesting strong buying opportunity
Trading volume is 7.3x average (14,819), indicating extremely strong buying pressure
MACD 0.1122 is above signal line 0.1073, indicating a bullish crossover

Stay Updated

Set price alerts, get AI analysis updates and real-time market news.